NCT06440278

Brief Summary

Sixty adults who have experienced acute coronary syndrome within the past 2-12 months from three states (Rhode Island, North Carolina, Minnesota) will be randomized to either (1) a coaching program for depressed mood and health behavior change (Behavioral Activation for Health and Depression; BA-HD), or (2) Enhanced Usual Care. This study will evaluate the feasibility and acceptability of study procedures and BA-HD, and establish protocol and measurement harmonization across three sites in preparation for a future multi-site efficacy trial.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jun 2024Jul 2026

First Submitted

Initial submission to the registry

May 28, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 3, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

June 13, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2026

Expected
Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

1.9 years

First QC Date

May 28, 2024

Last Update Submit

January 23, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Recruitment feasibility

    Number of participants randomized per month of recruitment

    Baseline

  • Study retention

    Proportion of randomized participants who complete the 6 month assessment.

    Week 26

  • Treatment engagement

    Dose of treatment received (i.e., session attendance)

    Week 13

  • Treatment Acceptability

    Client Satisfaction Questionnaire-8; Scores range from 8-32 with higher scores indicating greater treatment satisfaction.

    Week 13

Secondary Outcomes (18)

  • Cardiovascular Health

    Week 13, Week 26

  • Depressive symptoms

    Week 13, Week 26

  • 7 Day Moderate to Vigorous Physical Activity

    Week 13, Week 26

  • Self-Reported Moderate to Vigorous Physical Activity

    Week 13, Week 26

  • Self-Reported Diet

    Week 13, Week 26

  • +13 more secondary outcomes

Study Arms (2)

Behavioral Activation for Health and Depression

EXPERIMENTAL
Behavioral: Behavioral Activation for Health and Depression (BA-HD)

Enhanced Usual Care

ACTIVE COMPARATOR
Other: Enhanced Usual Care

Interventions

Patients will receive depression and heart disease education, as well as a list of local mental health resources.

Enhanced Usual Care

BA-HD includes 8 - 10 sessions delivered over 10-12 weeks. Sessions use behavioral activation techniques to connect patient core values with goal-setting targeting activities that improve mood, alongside personalized adjustments to cardiovascular health behaviors (i.e., tobacco cessation, medication adherence, physical activity, diet, and sleep). Educational materials and commercially available tools like activity trackers, pillboxes, and portion control aids will accompany the goal-setting process to facilitate behavior change.

Behavioral Activation for Health and Depression

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Medical chart-documented ACS (diagnosis of unstable angina, ST or non-ST elevation myocardial infarction) occurrence within the past 2-12 months.
  • Post-ACS depressed mood defined as a Patient Health Questionnaire(PHQ)--9 score ≥ 10 upon screening,
  • Non-adherence to and willingness to implement changes to ≥1 health behavior based on screening of:
  • Smoking/Tobacco exposure,
  • Physical Activity,
  • Diet,
  • Sleep health,
  • Medication adherence
  • English-language fluency
  • Resides within 90 minutes (driving time) of each site with no plans to relocate beyond that range during study participation
  • Access to a telephone and/or videoconferencing capability
  • Has primary care provider
  • Address at which packages can be received

You may not qualify if:

  • Chart indication of significant cognitive impairment (e.g., chart-documented dementia), Current exacerbation of serious mental illness,
  • Suicidality,
  • Hearing impairment that prevents telephone/video communication for intervention and assessment purposes,
  • Current hospice care, and
  • Current engagement in cardiac rehabilitation or other regular counseling treatment targeting depression or health behavior change

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hennepin Healthcare Research Institute

Minneapolis, Minnesota, 55415, United States

Location

ECU Health

Greenville, North Carolina, 27835, United States

Location

The Miriam Hospital

Providence, Rhode Island, 02903, United States

Location

MeSH Terms

Conditions

Acute Coronary Syndrome

Interventions

Health

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Population Characteristics

Study Officials

  • Emily Gathright, PhD

    The Miriam Hospital

    PRINCIPAL INVESTIGATOR
  • Andrew Busch, PhD

    Hennepin Healthcare Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

May 28, 2024

First Posted

June 3, 2024

Study Start

June 13, 2024

Primary Completion

April 30, 2026

Study Completion (Estimated)

July 15, 2026

Last Updated

January 27, 2026

Record last verified: 2026-01

Locations